Parameswaran Ramakrishnan, associate professor of pathology at ºÚÁϳԹÏÍø School of Medicine, received an award from JDRF, an organization dedicated to type 1 diabetes research.
Ramakrishnan was selected for a $600,000 strategic research agreement award, the .
The new award is to develop novel microRNA-based therapeutics for type 1 diabetes.
